Credit: Shutterstock photoVascular Solutions ( VASC ) just continues to deliver strong results. The company is constantly developing strong new products for its sales force to push into the medical instrument market, and its core products have consistently shown strong growth.
From Mairs & Power Small Cap Fund third quarter 2015 commentary.
Read More:
- Berkshire Investment Managers Having Mostly Positive Performance in 2015
- Medical Transcription Billing Corp. Insider Buys 20,000 Shares
- David Tepper's Appaloosa Management Boosts Exposure to Industrial Sector
- Mairs & Power Comments on Cray
- Warning! GuruFocus has detected 2 Warning Signs with ODP. Click here to check it out.
- ODP 15-Year Financial Data
- The intrinsic value of ODP
- Peter Lynch Chart of ODP
- Warning! GuruFocus has detected 2 Warning Sign with BRK.A. Click here to check it out.
- BRK.A 15-Year Financial Data
- The intrinsic value of BRK.A
- Peter Lynch Chart of BRK.A
- Warning! GuruFocus has detected 4 Warning Signs with DV. Click here to check it out.
- DV 15-Year Financial Data
- The intrinsic value of DV
- Peter Lynch Chart of DV
- Warning! GuruFocus has detected 4 Warning Signs with MTBC. Click here to check it out.
- MTBC 15-Year Financial Data
- The intrinsic value of MTBC
- Peter Lynch Chart of MTBC
- Warning! GuruFocus has detected 4 Warning Sign with VASC. Click here to check it out.
- VASC 15-Year Financial Data
- The intrinsic value of VASC
- Peter Lynch Chart of VASC
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
